To view the replay of the webcast, please click here.
Presentation
Get insights on:
… our internal and external innovation pipeline,
… our R&D activities in the Renal Care Continuum and beyond,
… how innovation is linked to our strategy,
… and how it contributes to growth.
Dr. Olaf Schermeier, Chief Executive Officer for Global Research and Development
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
FMC - Fresenius Medical Care AG & Co. KGaA published this content on 30 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 August 2022 00:10:07 UTC.